Document is current
Any future updates will be listed below
-
Authors
Hinte, Laura C. https://orcid.org/0000-0002-4226-0009
Castellano-Castillo, Daniel
Ghosh, Adhideb https://orcid.org/0000-0002-5160-4571
Melrose, Kate https://orcid.org/0000-0002-0170-0813
Gasser, Emanuel
Noé, Falko https://orcid.org/0009-0002-3360-5455
Massier, Lucas
Dong, Hua
Sun, Wenfei https://orcid.org/0000-0001-5762-6010
Hoffmann, Anne https://orcid.org/0000-0003-3258-3397
Wolfrum, Christian https://orcid.org/0000-0002-3862-6805
Rydén, Mikael https://orcid.org/0000-0003-4785-1876
Mejhert, Niklas https://orcid.org/0000-0003-1785-833X
Blüher, Matthias https://orcid.org/0000-0003-0208-2065
von Meyenn, Ferdinand https://orcid.org/0000-0001-9920-3075
- License Information
-
More Information
Article History
Received: 20 January 2023
Accepted: 7 October 2024
First Online: 18 November 2024
Competing interests
: M.B. received honoraria as a consultant and speaker from Amgen, AstraZeneca, Bayer, Boehringer-Ingelhiem, Lilly, Novo Nordisk and Sanofi. M.R. received honoraria as a consultant and speaker from AstraZeneca, Boehringer-Ingelheim, Lilly, Novo Nordisk and Sanofi. The other authors declare no competing interests.
